عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

Kate, Princess of Wales, Says She Has Cancer and Is Undergoing Chemotherapy

Britain's Catherine, Princess of Wales arrives at Westminster Abbey in central London on May 6, 2023, ahead of the coronations of Britain's King Charles III and Britain's Camilla, Queen Consort. Britain's Catherine announced cancer diagnosis on March 22, 2024. (AFP)
Britain's Catherine, Princess of Wales arrives at Westminster Abbey in central London on May 6, 2023, ahead of the coronations of Britain's King Charles III and Britain's Camilla, Queen Consort. Britain's Catherine announced cancer diagnosis on March 22, 2024. (AFP)
TT
TT

Kate, Princess of Wales, Says She Has Cancer and Is Undergoing Chemotherapy

Britain's Catherine, Princess of Wales arrives at Westminster Abbey in central London on May 6, 2023, ahead of the coronations of Britain's King Charles III and Britain's Camilla, Queen Consort. Britain's Catherine announced cancer diagnosis on March 22, 2024. (AFP)
Britain's Catherine, Princess of Wales arrives at Westminster Abbey in central London on May 6, 2023, ahead of the coronations of Britain's King Charles III and Britain's Camilla, Queen Consort. Britain's Catherine announced cancer diagnosis on March 22, 2024. (AFP)

Kate, the Princess of Wales, said Friday she has cancer and is undergoing chemotherapy.

The video announcement came after weeks of speculation spread on social media about her whereabouts and health since she was hospitalized in January for unspecified abdominal surgery.

Kate, 42, hadn’t been seen publicly since Christmas until video surfaced this week of her with her husband, Prince William, heir to the throne, walking from a farm shop near their Windsor home.

Kensington Palace had given little detail about Kate’s condition beyond saying it wasn’t cancer-related, the surgery was successful and recuperation would keep the princess away from public duties until April.

The news is another shock for the royal family since the announcement last month that King Charles III was being treated for an unspecified type of cancer that was caught while undergoing a procedure for a benign enlarged prostate.

Charles, 75, has withdrawn from public duties while he has cancer treatment, though he's appeared frequently in photos carrying on meetings with government officials and dignitaries and was even seen going to church.

Kate, on the other hand, had been out of view, leading to weeks of speculation and gossip. Attempts to put rumors to bed by releasing a photo of her on Mother's Day in the UK surrounded by her three smiling children backfired when The Associated Press and other news agencies retracted the image because it had been manipulated.

Kate issued a statement the next day acknowledging she liked to “experiment with editing” and apologizing for “any confusion” the photo had caused. But that did little to quell the speculation.

Even the footage published by The Sun and TMZ that appeared to show Kate and William shopping sparked a new flurry of rumor-mongering, with some armchair sleuths refusing to believe the video showed Kate at all.

Earlier this week, a British privacy watchdog said it was investigating a report that staff at the private London hospital where she was treated tried to snoop on her medical records while she was a patient for abdominal surgery.

The former Kate Middleton, who married William in a fairy-tale wedding in 2011, has boosted the popularity and appeal of the British monarchy worldwide more than any royal since Princess Diana.

The princess is the oldest of three children brought up in a well-to-do neighborhood in Berkshire, west of London. The Middletons have no aristocratic background, and the British press often referred to Kate as a “commoner” marrying into royalty.

Kate attended the private girls’ school Marlborough College and then University of St. Andrews in Scotland, where she met William around 2001. Friends and housemates at first, their relationship came to be in the public eye when they were pictured together on a skiing holiday in Switzerland in 2004.

Kate graduated in 2005 with a degree in art history and a budding relationship with the prince.

Most Viewed

 
 
Varieties

FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
TT
TT

FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights

US health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.

The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis, The AP reported.

Anaphylaxis occurs when the body's immune system develops a sudden, unexpected reaction to a foreign substance, such as food, insect stings or medications. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing.

The device, marketed as Neffy, could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers. Anaphylaxis sends more than 30,000 people to emergency rooms and results in more than 2,000 hospitalizations and more than 230 deaths in the US each year.

Of the 6 million prescriptions written for auto-injectors each year, more than 40% are never filled, Dr. Thomas Casale, an allergist at the University of South Florida, told an FDA advisory panel last year. Even when they are available to caregivers, many auto-injectors are used incorrectly, he said.

“There’s a real unmet medical need for a large portion of the population,” he said.

Neffy is intended for people who weigh at least 66 pounds. It is given in a single dose sprayed into one nostril. A second dose can be given if the person’s symptoms don’t improve.

The new treatment could be life-changing for people with severe food allergies, said Dr. Kelly Cleary, a pediatrician and director with the Food Allergy Research & Education, a nonprofit advocacy group.

“I have seen the look of worry or fear,” said Cleary, whose 11-year-old son has multiple food allergies. “I worry about what happens if someone hesitates.”

Requiring an injection in an emergency is as scary to some children as the allergic reaction itself. Some parents have had to restrain thrashing children to inject them, sometimes causing cuts that require stitches. About 3,500 caregivers a year are injured when they accidentally inject themselves in the hands, ARS said.

Priscilla Hernandez, of Pasadena, California said her 12-year-old son, Zacky, who is allergic to sesame, peanuts, tree nuts, avocado and other foods, was traumatized when he had a reaction at school about six years ago and a nurse treated him with an auto-injector.

“Having to do a shot creates this whole different level of anxiety,” she said.

She said, “we are over the moon” about the FDA's approval of the spray, which Zacky will start carrying when it becomes available.

First marketed in 1901, epinephrine predates the FDA itself. Products like the EpiPen auto-injector, approved in 1987, were authorized based on chemistry and manufacturing data and were not required to prove safety and efficacy.

Clinical trials of people experiencing potentially deadly reactions are difficult for ethical and pragmatic reasons. Instead, ARS officials compared the effect of the nasal spray on biological markers to existing epinephrine treatments.

Results showed Neffy worked about as well as injected epinephrine to boost heart rate and blood pressure, which counter severe reactions. The drug is combined with a patented agent that allows it to be easily absorbed through nasal membranes.